We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYH icon
3251
Community Health Systems
CYH
$423M
$1.51K ﹤0.01%
485
+288
+146% +$969
MRAM icon
3252
Everspin Technologies
MRAM
$405M
$1.5K ﹤0.01%
162
PRTH icon
3253
Priority Technology Holdings
PRTH
$444M
$1.5K ﹤0.01%
275
-86
-24% -$532
SEMR
3254
DELISTED
Semrush
SEMR
$1.5K ﹤0.01%
126
+89
+241% +$834
FINW icon
3255
FinWise Bancorp
FINW
$195M
$1.49K ﹤0.01%
83
+48
+137% +$877
SMHI icon
3256
SEACOR Marine Holdings
SMHI
$258M
$1.49K ﹤0.01%
247
-243
-50% -$1.6K
PLSE icon
3257
Pulse Biosciences
PLSE
$3.02B
$1.47K ﹤0.01%
107
-14
-12% -$218
WEYS icon
3258
Weyco Group
WEYS
$440M
$1.47K ﹤0.01%
48
-85
-64% -$2.6K
ATOM icon
3259
Atomera
ATOM
$214M
$1.45K ﹤0.01%
+658
New +$1.99K
GOSS icon
3260
Gossamer Bio
GOSS
$87M
$1.45K ﹤0.01%
+468
New +$1.33K
KVYO icon
3261
Klaviyo
KVYO
$4.73B
$1.43K ﹤0.01%
44
+25
+132% +$700
EPM icon
3262
Evolution Petroleum
EPM
$131M
$1.43K ﹤0.01%
403
+265
+192% +$1.12K
QLTY icon
3263
GMO US Quality ETF
QLTY
$5.07B
$1.42K ﹤0.01%
37
ADV icon
3264
Advantage Solutions
ADV
$361M
$1.41K ﹤0.01%
+64
New +$1.85K
MLAB icon
3265
Mesa Laboratories
MLAB
$574M
$1.41K ﹤0.01%
18
-19
-51% -$1.45K
DERM icon
3266
Journey Medical
DERM
$177M
$1.4K ﹤0.01%
182
+18
+11% +$141
SLS icon
3267
SELLAS Life Sciences
SLS
$2.36B
$1.4K ﹤0.01%
+372
New +$723
COSO
3268
CoastalSouth Bancshares
COSO
$337M
$1.4K ﹤0.01%
+60
New +$1.33K
LFST icon
3269
Lifestance Health
LFST
$4.14B
$1.39K ﹤0.01%
198
+86
+77% +$519
MG icon
3270
Mistras Group
MG
$512M
$1.39K ﹤0.01%
110
+81
+279% +$914
KRMD icon
3271
KORU Medical Systems
KRMD
$164M
$1.38K ﹤0.01%
+238
New +$1.14K
NGVC icon
3272
Vitamin Cottage Natural Grocers
NGVC
$654M
$1.38K ﹤0.01%
55
-136
-71% -$4.35K
ASPI icon
3273
ASP Isotopes
ASPI
$558M
$1.37K ﹤0.01%
256
+58
+29% +$461
PSNL icon
3274
Personalis
PSNL
$1.51B
$1.37K ﹤0.01%
172
+128
+291% +$1.12K
SLDB icon
3275
Solid Biosciences
SLDB
$900M
$1.36K ﹤0.01%
242
+146
+152% +$791

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.